HCV-IN-36
HCV-IN-36 (compound (S) -3h) is an orally active and potent HCV entry inhibitor. HCV-IN-36 shows excellent antiviral activity, with an EC50 of 0.016 μM and a CC50 (half-maximal cytotoxic concentration) of 8.78 μM[1].
Product Specifications
CAS Number
2757963-81-6
UNSPSC
12352005
Target
HCV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hcv-in-36.html
Solubility
10 mM in DMSO
Smiles
N#CC(C=CC(N(C)CCN(C)C)=C1)=C1CN(CC2)CCN2[C@@H](C3=CC=CC=C3)C4=CC=C(C=C4)Cl
Molecular Formula
C30H36ClN5
Molecular Weight
502.09
References & Citations
[1]Wang Y, Li J, Tan J, Yang B, Quan Y, Peng Z, Li Y, Li Z. Design, Synthesis, and Biological Evaluation of 2- ((4-Bisarylmethyl-piperazin-1-yl) methyl) benzonitrile Derivatives as HCV Entry Inhibitors. J Med Chem. 2022 Feb 10;65 (3) :2107-2121.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
HY-K6101A-01 100 mL
Human Breast Cancer Organoid Complete Culture Medium
Sign In for Pricing
View Details HY-K6101A-02 500 mL
Human Breast Cancer Organoid Complete Culture Medium
Sign In for Pricing
View Details MBS2168390-01 0.1 mL
HRP-Linked Polyclonal Antibody to Myosin VIIA (MYO7A)
Sign In for Pricing
View Details MBS2168390-02 0.2 mL
HRP-Linked Polyclonal Antibody to Myosin VIIA (MYO7A)
Sign In for Pricing
View Details MBS2168390-03 0.5 mL
HRP-Linked Polyclonal Antibody to Myosin VIIA (MYO7A)
Sign In for Pricing
View Details